Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._

Abstract Background Randomized, placebo-controlled clinical trials (RCTs) that include analytical treatment interruptions (ATI) are conducted to test the efficacy of HIV cure strategies. Two independent RCTs, AELIX-002 and AELIX-003, evaluated the HTI immunogen-based vaccines alone or combined with...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Lucia Bailón, Yovaninna Alarcón-Soto, José R. Arribas, Adrian Curran, Anuska Llano, Samandhy Cedeño, Roger Paredes, Elena Vendrame, Devi SenGupta, Jeffrey J. Wallin, Romas Geleziunas, Marie P. Malice, Ian McGowan, Christian Brander, José Moltó, Beatriz Mothe
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Nature Portfolio 2025-12-01
Sarja:	Communications Medicine
Linkit:	https://doi.org/10.1038/s43856-025-01266-y
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!